Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Pneumonia, Pneumococcal 1Neoplasms, Plasma Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT01245673 2020-04-06

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

University of Pennsylvania

Phase 2 Completed
28 enrolled 8 charts
Plasma cell

Neoplasms, Plasma Cell

NCT00323557 2012-12-05

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients

M.D. Anderson Cancer Center

Phase 2 Completed
39 enrolled 4 charts
LymphoidOther hematologic neoplasm

Leukemia, Pneumonia, Pneumococcal, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡